title: [Botulinum toxin A and physical therapy in gait in cerebral palsy].
abstract: BACKGROUND
  Cerebral palsy (PCI) is the leading cause of disability in children. Botulinum toxin type A (TBA) is a treatment to improve the function and pattern in the gait, although with a few studies that quantify the improvement.
  
  
  METHODS
  Quasi-experimental study was conducted from May 2010 to September 2011, in Integrated Rehabilitation Center, in 36 patients with spastic PCI. Was evaluated: functionality of travel by the scale of Koman, speed of the gait with tone scale of Ashworth and arches of passive mobility, were applied TBA and was sent to 10 sessions of physical therapy, with measurements taken before, the 1st and 4th month.
  
  
  RESULTS
  30 Patients completed the study, between the ages of 2 and 12 years, the majority had improvement in the functionality of the gear, tone, dorsiflexion and abduction of ankles to the motion, which was maintained at 4 months.
  
  
  CONCLUSIONS
  Botulinum toxin is an effective treatment to increase the arches of mobility and functionality of the gait of patients with hemiparesis and spastic paraparesis.
authors.affiliation: Departamento de Rehabilitación, Hospital General Regional No. 180, Instituto Mexicano del Seguro Social, Tlajomulco de Zúñiga, Jalisco, México. gassmed09@gmail.com.
authors.forename: Sandra Fabiola
authors.initials: SF
authors.lastname: García-Sánchez
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Gómez-Galindo
authors.forename: Jaime Eduardo
authors.initials: JE
authors.lastname: Guzmán-Pantoja
mesh_terms: D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005684:Gait / Q000187:drug effects; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D026741:Physical Therapy Modalities; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
keywords: Central nervous system diseases; Cerebral palsy; Neurologic gait disorders; Type A botulinum toxins